Security key
036752103
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 204,604,844
- Total 13F value
- $79,498,363,022
- Share change
- +4,086,205
- Put/Call ratio
- 71%
- SEC-reported price per share
- $388.96
- Number of holders
- 1,568
- Value change
- +$1,439,627,570
- Number of buys
- 713
- Number of sells
- 790
- Shares outstanding
- 232,836,241
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
1,568
Top holders
10
ELV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Elevance Health, Inc. SEC filings
Elevance Health, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 036752103
Recent filing periods:
Ownership snapshot
Top reported holders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
14 May 2025
13F
13D/G
3/4/5
Lead comparable stake: 7.8%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 7.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
7.8%
R. Kerry Clark
0%
VANGUARD GROUP INC
9.5%
STATE STREET CORP
4.6%
PRICE T ROWE ASSOCIATES INC /MD/
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
7.8%
from 13D/G
|
$9,269,439,181
21,311,015 shares
|
— | 31 Mar 2025 |
| R. Kerry Clark |
3/4/5
Director
|
0%
|
$3,987,586
9,640 shares
|
— | 14 May 2025 |
| VANGUARD GROUP INC |
13F
Company
|
9.5%
|
$9,635,280,896
22,152,108 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
4.6%
|
$4,631,324,897
10,647,703 shares
|
— | 31 Mar 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.9%
|
$3,976,650,000
9,142,563 shares
|
— | 31 Mar 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.5%
|
$2,520,503,599
5,794,794 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1,568
Shares
204,604,844
Rows available
1,568
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
1,638
Q2 2025 holders
1,568
Holder diff
-70
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend